Table of Content

1 Semi-solid Dosage Market Overview
1.1 Product Overview and Scope of Semi-solid Dosage
1.2 Semi-solid Dosage Segment by Type
1.2.1 Global Semi-solid Dosage Market Value Comparison by Type (2024-2034)
1.2.2 Ointment
1.2.3 Paste
1.2.4 Plaster
1.2.5 Gel
1.3 Semi-solid Dosage Segment by Application
1.3.1 Global Semi-solid Dosage Market Value by Application: (2024-2034)
1.3.2 Skin
1.3.3 Nasal Cavity
1.3.4 Vaginal Cavity
1.3.5 Rectal Cavity
1.3.6 Others
1.4 Global Semi-solid Dosage Market Size Estimates and Forecasts
1.4.1 Global Semi-solid Dosage Revenue 2018-2029
1.4.2 Global Semi-solid Dosage Sales 2018-2029
1.4.3 Global Semi-solid Dosage Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Semi-solid Dosage Market Competition by Manufacturers
2.1 Global Semi-solid Dosage Sales Market Share by Manufacturers (2018-2024)
2.2 Global Semi-solid Dosage Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Semi-solid Dosage Average Price by Manufacturers (2018-2024)
2.4 Global Semi-solid Dosage Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Semi-solid Dosage, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Semi-solid Dosage, Product Type & Application
2.7 Semi-solid Dosage Market Competitive Situation and Trends
2.7.1 Semi-solid Dosage Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Semi-solid Dosage Players Market Share by Revenue
2.7.3 Global Semi-solid Dosage Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Semi-solid Dosage Retrospective Market Scenario by Region
3.1 Global Semi-solid Dosage Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Semi-solid Dosage Global Semi-solid Dosage Sales by Region: 2018-2029
3.2.1 Global Semi-solid Dosage Sales by Region: 2018-2024
3.2.2 Global Semi-solid Dosage Sales by Region: 2024-2029
3.3 Global Semi-solid Dosage Global Semi-solid Dosage Revenue by Region: 2018-2029
3.3.1 Global Semi-solid Dosage Revenue by Region: 2018-2024
3.3.2 Global Semi-solid Dosage Revenue by Region: 2024-2029
3.4 North America Semi-solid Dosage Market Facts & Figures by Country
3.4.1 North America Semi-solid Dosage Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Semi-solid Dosage Sales by Country (2018-2029)
3.4.3 North America Semi-solid Dosage Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Semi-solid Dosage Market Facts & Figures by Country
3.5.1 Europe Semi-solid Dosage Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Semi-solid Dosage Sales by Country (2018-2029)
3.5.3 Europe Semi-solid Dosage Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Semi-solid Dosage Market Facts & Figures by Country
3.6.1 Asia Pacific Semi-solid Dosage Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Semi-solid Dosage Sales by Country (2018-2029)
3.6.3 Asia Pacific Semi-solid Dosage Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Semi-solid Dosage Market Facts & Figures by Country
3.7.1 Latin America Semi-solid Dosage Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Semi-solid Dosage Sales by Country (2018-2029)
3.7.3 Latin America Semi-solid Dosage Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Semi-solid Dosage Market Facts & Figures by Country
3.8.1 Middle East and Africa Semi-solid Dosage Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Semi-solid Dosage Sales by Country (2018-2029)
3.8.3 Middle East and Africa Semi-solid Dosage Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Semi-solid Dosage Sales by Type (2018-2029)
4.1.1 Global Semi-solid Dosage Sales by Type (2018-2024)
4.1.2 Global Semi-solid Dosage Sales by Type (2024-2029)
4.1.3 Global Semi-solid Dosage Sales Market Share by Type (2018-2029)
4.2 Global Semi-solid Dosage Revenue by Type (2018-2029)
4.2.1 Global Semi-solid Dosage Revenue by Type (2018-2024)
4.2.2 Global Semi-solid Dosage Revenue by Type (2024-2029)
4.2.3 Global Semi-solid Dosage Revenue Market Share by Type (2018-2029)
4.3 Global Semi-solid Dosage Price by Type (2018-2029)
5 Segment by Application
5.1 Global Semi-solid Dosage Sales by Application (2018-2029)
5.1.1 Global Semi-solid Dosage Sales by Application (2018-2024)
5.1.2 Global Semi-solid Dosage Sales by Application (2024-2029)
5.1.3 Global Semi-solid Dosage Sales Market Share by Application (2018-2029)
5.2 Global Semi-solid Dosage Revenue by Application (2018-2029)
5.2.1 Global Semi-solid Dosage Revenue by Application (2018-2024)
5.2.2 Global Semi-solid Dosage Revenue by Application (2024-2029)
5.2.3 Global Semi-solid Dosage Revenue Market Share by Application (2018-2029)
5.3 Global Semi-solid Dosage Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Corporation Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Johnson & Johnson Semi-solid Dosage Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Merck & Co
6.2.1 Merck & Co Corporation Information
6.2.2 Merck & Co Description and Business Overview
6.2.3 Merck & Co Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Merck & Co Semi-solid Dosage Product Portfolio
6.2.5 Merck & Co Recent Developments/Updates
6.3 Bayer AG
6.3.1 Bayer AG Corporation Information
6.3.2 Bayer AG Description and Business Overview
6.3.3 Bayer AG Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Bayer AG Semi-solid Dosage Product Portfolio
6.3.5 Bayer AG Recent Developments/Updates
6.4 Hisamitsu Pharmaceutical
6.4.1 Hisamitsu Pharmaceutical Corporation Information
6.4.2 Hisamitsu Pharmaceutical Description and Business Overview
6.4.3 Hisamitsu Pharmaceutical Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Hisamitsu Pharmaceutical Semi-solid Dosage Product Portfolio
6.4.5 Hisamitsu Pharmaceutical Recent Developments/Updates
6.5 Glenmark Pharmaceuticals
6.5.1 Glenmark Pharmaceuticals Corporation Information
6.5.2 Glenmark Pharmaceuticals Description and Business Overview
6.5.3 Glenmark Pharmaceuticals Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Glenmark Pharmaceuticals Semi-solid Dosage Product Portfolio
6.5.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.6 Cipla Ltd
6.6.1 Cipla Ltd Corporation Information
6.6.2 Cipla Ltd Description and Business Overview
6.6.3 Cipla Ltd Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Cipla Ltd Semi-solid Dosage Product Portfolio
6.6.5 Cipla Ltd Recent Developments/Updates
6.7 Nestle SA
6.6.1 Nestle SA Corporation Information
6.6.2 Nestle SA Description and Business Overview
6.6.3 Nestle SA Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Nestle SA Semi-solid Dosage Product Portfolio
6.7.5 Nestle SA Recent Developments/Updates
6.8 Novartis AG
6.8.1 Novartis AG Corporation Information
6.8.2 Novartis AG Description and Business Overview
6.8.3 Novartis AG Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Novartis AG Semi-solid Dosage Product Portfolio
6.8.5 Novartis AG Recent Developments/Updates
6.9 GlaxoSmithKline plc
6.9.1 GlaxoSmithKline plc Corporation Information
6.9.2 GlaxoSmithKline plc Description and Business Overview
6.9.3 GlaxoSmithKline plc Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
6.9.4 GlaxoSmithKline plc Semi-solid Dosage Product Portfolio
6.9.5 GlaxoSmithKline plc Recent Developments/Updates
6.10 Bausch Health Companies
6.10.1 Bausch Health Companies Corporation Information
6.10.2 Bausch Health Companies Description and Business Overview
6.10.3 Bausch Health Companies Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Bausch Health Companies Semi-solid Dosage Product Portfolio
6.10.5 Bausch Health Companies Recent Developments/Updates
6.11 Allergan
6.11.1 Allergan Corporation Information
6.11.2 Allergan Semi-solid Dosage Description and Business Overview
6.11.3 Allergan Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Allergan Semi-solid Dosage Product Portfolio
6.11.5 Allergan Recent Developments/Updates
6.12 Biofrontera
6.12.1 Biofrontera Corporation Information
6.12.2 Biofrontera Semi-solid Dosage Description and Business Overview
6.12.3 Biofrontera Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Biofrontera Semi-solid Dosage Product Portfolio
6.12.5 Biofrontera Recent Developments/Updates
6.13 Crown Laboratories
6.13.1 Crown Laboratories Corporation Information
6.13.2 Crown Laboratories Semi-solid Dosage Description and Business Overview
6.13.3 Crown Laboratories Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Crown Laboratories Semi-solid Dosage Product Portfolio
6.13.5 Crown Laboratories Recent Developments/Updates
6.14 Akorn
6.14.1 Akorn Corporation Information
6.14.2 Akorn Semi-solid Dosage Description and Business Overview
6.14.3 Akorn Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Akorn Semi-solid Dosage Product Portfolio
6.14.5 Akorn Recent Developments/Updates
6.15 Ingenus Pharmaceuticals
6.15.1 Ingenus Pharmaceuticals Corporation Information
6.15.2 Ingenus Pharmaceuticals Semi-solid Dosage Description and Business Overview
6.15.3 Ingenus Pharmaceuticals Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Ingenus Pharmaceuticals Semi-solid Dosage Product Portfolio
6.15.5 Ingenus Pharmaceuticals Recent Developments/Updates
6.16 Sun Pharmaceuticals
6.16.1 Sun Pharmaceuticals Corporation Information
6.16.2 Sun Pharmaceuticals Semi-solid Dosage Description and Business Overview
6.16.3 Sun Pharmaceuticals Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Sun Pharmaceuticals Semi-solid Dosage Product Portfolio
6.16.5 Sun Pharmaceuticals Recent Developments/Updates
6.17 Crescita Therapeutics
6.17.1 Crescita Therapeutics Corporation Information
6.17.2 Crescita Therapeutics Semi-solid Dosage Description and Business Overview
6.17.3 Crescita Therapeutics Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Crescita Therapeutics Semi-solid Dosage Product Portfolio
6.17.5 Crescita Therapeutics Recent Developments/Updates
6.18 Mylan N.V.
6.18.1 Mylan N.V. Corporation Information
6.18.2 Mylan N.V. Semi-solid Dosage Description and Business Overview
6.18.3 Mylan N.V. Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
6.18.4 Mylan N.V. Semi-solid Dosage Product Portfolio
6.18.5 Mylan N.V. Recent Developments/Updates
6.19 Encore Dermatology
6.19.1 Encore Dermatology Corporation Information
6.19.2 Encore Dermatology Semi-solid Dosage Description and Business Overview
6.19.3 Encore Dermatology Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
6.19.4 Encore Dermatology Semi-solid Dosage Product Portfolio
6.19.5 Encore Dermatology Recent Developments/Updates
6.20 LEO Pharma
6.20.1 LEO Pharma Corporation Information
6.20.2 LEO Pharma Semi-solid Dosage Description and Business Overview
6.20.3 LEO Pharma Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
6.20.4 LEO Pharma Semi-solid Dosage Product Portfolio
6.20.5 LEO Pharma Recent Developments/Updates
6.21 Almirall, S.A
6.21.1 Almirall, S.A Corporation Information
6.21.2 Almirall, S.A Semi-solid Dosage Description and Business Overview
6.21.3 Almirall, S.A Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
6.21.4 Almirall, S.A Semi-solid Dosage Product Portfolio
6.21.5 Almirall, S.A Recent Developments/Updates
6.22 Aclaris Therapeutics
6.22.1 Aclaris Therapeutics Corporation Information
6.22.2 Aclaris Therapeutics Semi-solid Dosage Description and Business Overview
6.22.3 Aclaris Therapeutics Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
6.22.4 Aclaris Therapeutics Semi-solid Dosage Product Portfolio
6.22.5 Aclaris Therapeutics Recent Developments/Updates
6.23 Taro Pharmaceutical Industries
6.23.1 Taro Pharmaceutical Industries Corporation Information
6.23.2 Taro Pharmaceutical Industries Semi-solid Dosage Description and Business Overview
6.23.3 Taro Pharmaceutical Industries Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
6.23.4 Taro Pharmaceutical Industries Semi-solid Dosage Product Portfolio
6.23.5 Taro Pharmaceutical Industries Recent Developments/Updates
6.24 Teligent Pharma
6.24.1 Teligent Pharma Corporation Information
6.24.2 Teligent Pharma Semi-solid Dosage Description and Business Overview
6.24.3 Teligent Pharma Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
6.24.4 Teligent Pharma Semi-solid Dosage Product Portfolio
6.24.5 Teligent Pharma Recent Developments/Updates
6.25 Perrigo Pharma
6.25.1 Perrigo Pharma Corporation Information
6.25.2 Perrigo Pharma Semi-solid Dosage Description and Business Overview
6.25.3 Perrigo Pharma Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
6.25.4 Perrigo Pharma Semi-solid Dosage Product Portfolio
6.25.5 Perrigo Pharma Recent Developments/Updates
6.26 SigmaAldrich
6.26.1 SigmaAldrich Corporation Information
6.26.2 SigmaAldrich Semi-solid Dosage Description and Business Overview
6.26.3 SigmaAldrich Semi-solid Dosage Sales, Revenue and Gross Margin (2018-2024)
6.26.4 SigmaAldrich Semi-solid Dosage Product Portfolio
6.26.5 SigmaAldrich Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Semi-solid Dosage Industry Chain Analysis
7.2 Semi-solid Dosage Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Semi-solid Dosage Production Mode & Process
7.4 Semi-solid Dosage Sales and Marketing
7.4.1 Semi-solid Dosage Sales Channels
7.4.2 Semi-solid Dosage Distributors
7.5 Semi-solid Dosage Customers
8 Semi-solid Dosage Market Dynamics
8.1 Semi-solid Dosage Industry Trends
8.2 Semi-solid Dosage Market Drivers
8.3 Semi-solid Dosage Market Challenges
8.4 Semi-solid Dosage Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Semi-solid Dosage Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Semi-solid Dosage Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Semi-solid Dosage Market Competitive Situation by Manufacturers in 2022
Table 4. Global Semi-solid Dosage Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Semi-solid Dosage Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Semi-solid Dosage Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Semi-solid Dosage Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Semi-solid Dosage Average Price (USD/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Semi-solid Dosage, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Semi-solid Dosage, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Semi-solid Dosage, Product Type & Application
Table 12. Global Key Manufacturers of Semi-solid Dosage, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Semi-solid Dosage by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Semi-solid Dosage as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Semi-solid Dosage Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Semi-solid Dosage Sales by Region (2018-2024) & (K Units)
Table 18. Global Semi-solid Dosage Sales Market Share by Region (2018-2024)
Table 19. Global Semi-solid Dosage Sales by Region (2024-2029) & (K Units)
Table 20. Global Semi-solid Dosage Sales Market Share by Region (2024-2029)
Table 21. Global Semi-solid Dosage Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Semi-solid Dosage Revenue Market Share by Region (2018-2024)
Table 23. Global Semi-solid Dosage Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Semi-solid Dosage Revenue Market Share by Region (2024-2029)
Table 25. North America Semi-solid Dosage Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Semi-solid Dosage Sales by Country (2018-2024) & (K Units)
Table 27. North America Semi-solid Dosage Sales by Country (2024-2029) & (K Units)
Table 28. North America Semi-solid Dosage Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Semi-solid Dosage Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Semi-solid Dosage Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Semi-solid Dosage Sales by Country (2018-2024) & (K Units)
Table 32. Europe Semi-solid Dosage Sales by Country (2024-2029) & (K Units)
Table 33. Europe Semi-solid Dosage Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Semi-solid Dosage Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Semi-solid Dosage Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Semi-solid Dosage Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Semi-solid Dosage Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Semi-solid Dosage Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Semi-solid Dosage Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Semi-solid Dosage Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Semi-solid Dosage Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Semi-solid Dosage Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Semi-solid Dosage Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Semi-solid Dosage Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Semi-solid Dosage Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Semi-solid Dosage Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Semi-solid Dosage Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Semi-solid Dosage Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Semi-solid Dosage Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Semi-solid Dosage Sales (K Units) by Type (2018-2024)
Table 51. Global Semi-solid Dosage Sales (K Units) by Type (2024-2029)
Table 52. Global Semi-solid Dosage Sales Market Share by Type (2018-2024)
Table 53. Global Semi-solid Dosage Sales Market Share by Type (2024-2029)
Table 54. Global Semi-solid Dosage Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Semi-solid Dosage Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Semi-solid Dosage Revenue Market Share by Type (2018-2024)
Table 57. Global Semi-solid Dosage Revenue Market Share by Type (2024-2029)
Table 58. Global Semi-solid Dosage Price (USD/Unit) by Type (2018-2024)
Table 59. Global Semi-solid Dosage Price (USD/Unit) by Type (2024-2029)
Table 60. Global Semi-solid Dosage Sales (K Units) by Application (2018-2024)
Table 61. Global Semi-solid Dosage Sales (K Units) by Application (2024-2029)
Table 62. Global Semi-solid Dosage Sales Market Share by Application (2018-2024)
Table 63. Global Semi-solid Dosage Sales Market Share by Application (2024-2029)
Table 64. Global Semi-solid Dosage Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Semi-solid Dosage Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Semi-solid Dosage Revenue Market Share by Application (2018-2024)
Table 67. Global Semi-solid Dosage Revenue Market Share by Application (2024-2029)
Table 68. Global Semi-solid Dosage Price (USD/Unit) by Application (2018-2024)
Table 69. Global Semi-solid Dosage Price (USD/Unit) by Application (2024-2029)
Table 70. Johnson & Johnson Corporation Information
Table 71. Johnson & Johnson Description and Business Overview
Table 72. Johnson & Johnson Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 73. Johnson & Johnson Semi-solid Dosage Product
Table 74. Johnson & Johnson Recent Developments/Updates
Table 75. Merck & Co Corporation Information
Table 76. Merck & Co Description and Business Overview
Table 77. Merck & Co Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 78. Merck & Co Semi-solid Dosage Product
Table 79. Merck & Co Recent Developments/Updates
Table 80. Bayer AG Corporation Information
Table 81. Bayer AG Description and Business Overview
Table 82. Bayer AG Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 83. Bayer AG Semi-solid Dosage Product
Table 84. Bayer AG Recent Developments/Updates
Table 85. Hisamitsu Pharmaceutical Corporation Information
Table 86. Hisamitsu Pharmaceutical Description and Business Overview
Table 87. Hisamitsu Pharmaceutical Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 88. Hisamitsu Pharmaceutical Semi-solid Dosage Product
Table 89. Hisamitsu Pharmaceutical Recent Developments/Updates
Table 90. Glenmark Pharmaceuticals Corporation Information
Table 91. Glenmark Pharmaceuticals Description and Business Overview
Table 92. Glenmark Pharmaceuticals Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 93. Glenmark Pharmaceuticals Semi-solid Dosage Product
Table 94. Glenmark Pharmaceuticals Recent Developments/Updates
Table 95. Cipla Ltd Corporation Information
Table 96. Cipla Ltd Description and Business Overview
Table 97. Cipla Ltd Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 98. Cipla Ltd Semi-solid Dosage Product
Table 99. Cipla Ltd Recent Developments/Updates
Table 100. Nestle SA Corporation Information
Table 101. Nestle SA Description and Business Overview
Table 102. Nestle SA Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 103. Nestle SA Semi-solid Dosage Product
Table 104. Nestle SA Recent Developments/Updates
Table 105. Novartis AG Corporation Information
Table 106. Novartis AG Description and Business Overview
Table 107. Novartis AG Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 108. Novartis AG Semi-solid Dosage Product
Table 109. Novartis AG Recent Developments/Updates
Table 110. GlaxoSmithKline plc Corporation Information
Table 111. GlaxoSmithKline plc Description and Business Overview
Table 112. GlaxoSmithKline plc Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 113. GlaxoSmithKline plc Semi-solid Dosage Product
Table 114. GlaxoSmithKline plc Recent Developments/Updates
Table 115. Bausch Health Companies Corporation Information
Table 116. Bausch Health Companies Description and Business Overview
Table 117. Bausch Health Companies Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 118. Bausch Health Companies Semi-solid Dosage Product
Table 119. Bausch Health Companies Recent Developments/Updates
Table 120. Allergan Corporation Information
Table 121. Allergan Description and Business Overview
Table 122. Allergan Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 123. Allergan Semi-solid Dosage Product
Table 124. Allergan Recent Developments/Updates
Table 125. Biofrontera Corporation Information
Table 126. Biofrontera Description and Business Overview
Table 127. Biofrontera Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 128. Biofrontera Semi-solid Dosage Product
Table 129. Biofrontera Recent Developments/Updates
Table 130. Crown Laboratories Corporation Information
Table 131. Crown Laboratories Description and Business Overview
Table 132. Crown Laboratories Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 133. Crown Laboratories Semi-solid Dosage Product
Table 134. Crown Laboratories Recent Developments/Updates
Table 135. Akorn Corporation Information
Table 136. Akorn Description and Business Overview
Table 137. Akorn Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 138. Akorn Semi-solid Dosage Product
Table 139. Akorn Recent Developments/Updates
Table 140. Ingenus Pharmaceuticals Corporation Information
Table 141. Ingenus Pharmaceuticals Description and Business Overview
Table 142. Ingenus Pharmaceuticals Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 143. Ingenus Pharmaceuticals Semi-solid Dosage Product
Table 144. Ingenus Pharmaceuticals Recent Developments/Updates
Table 145. Sun Pharmaceuticals Corporation Information
Table 146. Sun Pharmaceuticals Description and Business Overview
Table 147. Sun Pharmaceuticals Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 148. Sun Pharmaceuticals Semi-solid Dosage Product
Table 149. Sun Pharmaceuticals Recent Developments/Updates
Table 150. Crescita Therapeutics Corporation Information
Table 151. Crescita Therapeutics Description and Business Overview
Table 152. Crescita Therapeutics Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 153. Crescita Therapeutics Semi-solid Dosage Product
Table 154. Crescita Therapeutics Recent Developments/Updates
Table 155. Mylan N.V. Corporation Information
Table 156. Mylan N.V. Description and Business Overview
Table 157. Mylan N.V. Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 158. Mylan N.V. Semi-solid Dosage Product
Table 159. Mylan N.V. Recent Developments/Updates
Table 160. Encore Dermatology Corporation Information
Table 161. Encore Dermatology Description and Business Overview
Table 162. Encore Dermatology Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 163. Encore Dermatology Semi-solid Dosage Product
Table 164. Encore Dermatology Recent Developments/Updates
Table 165. LEO Pharma Corporation Information
Table 166. LEO Pharma Description and Business Overview
Table 167. LEO Pharma Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 168. LEO Pharma Semi-solid Dosage Product
Table 169. LEO Pharma Recent Developments/Updates
Table 170. Almirall, S.A Corporation Information
Table 171. Almirall, S.A Description and Business Overview
Table 172. Almirall, S.A Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 173. Almirall, S.A Semi-solid Dosage Product
Table 174. Almirall, S.A Recent Developments/Updates
Table 175. Aclaris Therapeutics Corporation Information
Table 176. Aclaris Therapeutics Description and Business Overview
Table 177. Aclaris Therapeutics Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 178. Aclaris Therapeutics Semi-solid Dosage Product
Table 179. Aclaris Therapeutics Recent Developments/Updates
Table 180. Taro Pharmaceutical Industries Corporation Information
Table 181. Taro Pharmaceutical Industries Description and Business Overview
Table 182. Taro Pharmaceutical Industries Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 183. Taro Pharmaceutical Industries Semi-solid Dosage Product
Table 184. Taro Pharmaceutical Industries Recent Developments/Updates
Table 185. Teligent Pharma Corporation Information
Table 186. Teligent Pharma Description and Business Overview
Table 187. Teligent Pharma Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 188. Teligent Pharma Semi-solid Dosage Product
Table 189. Teligent Pharma Recent Developments/Updates
Table 190. Perrigo Pharma Corporation Information
Table 191. Perrigo Pharma Description and Business Overview
Table 192. Perrigo Pharma Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 193. Perrigo Pharma Semi-solid Dosage Product
Table 194. Perrigo Pharma Recent Developments/Updates
Table 195. SigmaAldrich Corporation Information
Table 196. SigmaAldrich Description and Business Overview
Table 197. SigmaAldrich Semi-solid Dosage Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 198. SigmaAldrich Semi-solid Dosage Product
Table 199. SigmaAldrich Recent Developments/Updates
Table 200. Key Raw Materials Lists
Table 201. Raw Materials Key Suppliers Lists
Table 202. Semi-solid Dosage Distributors List
Table 203. Semi-solid Dosage Customers List
Table 204. Semi-solid Dosage Market Trends
Table 205. Semi-solid Dosage Market Drivers
Table 206. Semi-solid Dosage Market Challenges
Table 207. Semi-solid Dosage Market Restraints
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Semi-solid Dosage
Figure 2. Global Semi-solid Dosage Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Semi-solid Dosage Market Share by Type in 2022 & 2029
Figure 4. Ointment Product Picture
Figure 5. Paste Product Picture
Figure 6. Plaster Product Picture
Figure 7. Gel Product Picture
Figure 8. Global Semi-solid Dosage Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Semi-solid Dosage Market Share by Application in 2022 & 2029
Figure 10. Skin
Figure 11. Nasal Cavity
Figure 12. Vaginal Cavity
Figure 13. Rectal Cavity
Figure 14. Others
Figure 15. Global Semi-solid Dosage Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Semi-solid Dosage Market Size (2018-2029) & (US$ Million)
Figure 17. Global Semi-solid Dosage Sales (2018-2029) & (K Units)
Figure 18. Global Semi-solid Dosage Average Price (USD/Unit) & (2018-2029)
Figure 19. Semi-solid Dosage Report Years Considered
Figure 20. Semi-solid Dosage Sales Share by Manufacturers in 2022
Figure 21. Global Semi-solid Dosage Revenue Share by Manufacturers in 2022
Figure 22. The Global 5 and 10 Largest Semi-solid Dosage Players: Market Share by Revenue in 2022
Figure 23. Semi-solid Dosage Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 24. Global Semi-solid Dosage Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 25. North America Semi-solid Dosage Sales Market Share by Country (2018-2029)
Figure 26. North America Semi-solid Dosage Revenue Market Share by Country (2018-2029)
Figure 27. United States Semi-solid Dosage Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Canada Semi-solid Dosage Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Europe Semi-solid Dosage Sales Market Share by Country (2018-2029)
Figure 30. Europe Semi-solid Dosage Revenue Market Share by Country (2018-2029)
Figure 31. Germany Semi-solid Dosage Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. France Semi-solid Dosage Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. U.K. Semi-solid Dosage Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Italy Semi-solid Dosage Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Russia Semi-solid Dosage Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Asia Pacific Semi-solid Dosage Sales Market Share by Region (2018-2029)
Figure 37. Asia Pacific Semi-solid Dosage Revenue Market Share by Region (2018-2029)
Figure 38. China Semi-solid Dosage Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan Semi-solid Dosage Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea Semi-solid Dosage Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India Semi-solid Dosage Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia Semi-solid Dosage Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. China Taiwan Semi-solid Dosage Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Indonesia Semi-solid Dosage Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Thailand Semi-solid Dosage Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Malaysia Semi-solid Dosage Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Latin America Semi-solid Dosage Sales Market Share by Country (2018-2029)
Figure 48. Latin America Semi-solid Dosage Revenue Market Share by Country (2018-2029)
Figure 49. Mexico Semi-solid Dosage Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Brazil Semi-solid Dosage Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Argentina Semi-solid Dosage Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Middle East & Africa Semi-solid Dosage Sales Market Share by Country (2018-2029)
Figure 53. Middle East & Africa Semi-solid Dosage Revenue Market Share by Country (2018-2029)
Figure 54. Turkey Semi-solid Dosage Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Semi-solid Dosage Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. UAE Semi-solid Dosage Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Global Sales Market Share of Semi-solid Dosage by Type (2018-2029)
Figure 58. Global Revenue Market Share of Semi-solid Dosage by Type (2018-2029)
Figure 59. Global Semi-solid Dosage Price (USD/Unit) by Type (2018-2029)
Figure 60. Global Sales Market Share of Semi-solid Dosage by Application (2018-2029)
Figure 61. Global Revenue Market Share of Semi-solid Dosage by Application (2018-2029)
Figure 62. Global Semi-solid Dosage Price (USD/Unit) by Application (2018-2029)
Figure 63. Semi-solid Dosage Value Chain
Figure 64. Semi-solid Dosage Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed